Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kylee Maclachlan

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Best Practice & Research. Clinical Haematology|March 7, 2020
Maintenance therapy and need for cessation studies in multiple myeloma: Focus on the futureBenjamin Diamond, Kylee Maclachlan, David J Chung, et al.
Best Practice & Research. Clinical Haematology|March 7, 2020
Second malignancies in multiple myeloma; emerging patterns and future directionsKylee Maclachlan, Benjamin Diamond, Francesco Maura, et al.
Blood Reviews|August 11, 2020
Defining the undetectable: The current landscape of minimal residual disease assessment in multiple myeloma and goals for future clarityBenjamin T Diamond, Even Rustad, Kylee Maclachlan, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Impact of rare structural variant events in newly diagnosed multiple myelomaMonika Chojnacka, Benjamin Diamond, Bachisio Ziccheddu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2023
Impact of Rare Structural Variant Events in Newly Diagnosed Multiple MyelomaMonika Chojnacka, Benjamin Diamond, Bachisio Ziccheddu, et al.
Bioinformatics (Oxford, England)|July 8, 2025
AncestryGeni: a novel genetic ancestry classification pipeline for small and noisy sequence dataEran Elhaik, Sara Behnamian, Michael Howe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2024
Genomic Profiling to Contextualize the Results of Intervention for Smoldering Multiple MyelomaDickran Kazandjian, Benjamin Diamond, Marios Papadimitriou, et al.
Seminars in Cell & Developmental Biology|May 7, 2021
Chromothripsis as a pathogenic driver of multiple myelomaFrancesco Maura, Eileen M Boyle, Even H Rustad, et al.
Research Square|March 3, 2023
Bortezomib, Lenalidomide and Dexamethasone (VRd) vs Carfilzomib, Lenalidomide and Dexamethasone (KRd) as Induction Therapy in Newly Diagnosed Multiple MyelomaCarlyn Rose Tan, Andriy Derkach, David Nemirovsky, et al.
Hemasphere|April 20, 2026
Whole-genome sequencing of cell-free DNA for assessment of minimal residual disease in high-risk smoldering multiple myelomaChrissy Baker, Elizabeth Hill, Dickran Kazandjian, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Best Practice & Research. Clinical Haematology|March 7, 2020
Maintenance therapy and need for cessation studies in multiple myeloma: Focus on the futureBenjamin Diamond, Kylee Maclachlan, David J Chung, et al.
Best Practice & Research. Clinical Haematology|March 7, 2020
Second malignancies in multiple myeloma; emerging patterns and future directionsKylee Maclachlan, Benjamin Diamond, Francesco Maura, et al.
Blood Reviews|August 11, 2020
Defining the undetectable: The current landscape of minimal residual disease assessment in multiple myeloma and goals for future clarityBenjamin T Diamond, Even Rustad, Kylee Maclachlan, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Impact of rare structural variant events in newly diagnosed multiple myelomaMonika Chojnacka, Benjamin Diamond, Bachisio Ziccheddu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2023
Impact of Rare Structural Variant Events in Newly Diagnosed Multiple MyelomaMonika Chojnacka, Benjamin Diamond, Bachisio Ziccheddu, et al.
Bioinformatics (Oxford, England)|July 8, 2025
AncestryGeni: a novel genetic ancestry classification pipeline for small and noisy sequence dataEran Elhaik, Sara Behnamian, Michael Howe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2024
Genomic Profiling to Contextualize the Results of Intervention for Smoldering Multiple MyelomaDickran Kazandjian, Benjamin Diamond, Marios Papadimitriou, et al.
Seminars in Cell & Developmental Biology|May 7, 2021
Chromothripsis as a pathogenic driver of multiple myelomaFrancesco Maura, Eileen M Boyle, Even H Rustad, et al.
Research Square|March 3, 2023
Bortezomib, Lenalidomide and Dexamethasone (VRd) vs Carfilzomib, Lenalidomide and Dexamethasone (KRd) as Induction Therapy in Newly Diagnosed Multiple MyelomaCarlyn Rose Tan, Andriy Derkach, David Nemirovsky, et al.
Hemasphere|April 20, 2026
Whole-genome sequencing of cell-free DNA for assessment of minimal residual disease in high-risk smoldering multiple myelomaChrissy Baker, Elizabeth Hill, Dickran Kazandjian, et al.
Pageof 4